A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease
Clinical trial NCT02580617 · UNKNOWN
Trial details
- NCT number
- NCT02580617
- Sponsor
- Anterogen Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-09
- Primary completion
- 2023-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.